This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n10http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n6https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q59217098
rdf:type
wikibase:Item
schema:description
հոդված article article scientifique publié en 2008 wetenschappelijk artikel наукова стаття, опублікована у 2008
p:P577
wds:Q59217098-81EB9DA6-95D7-4615-9297-50DA594F55B1
wdt:P577
2008-01-01T00:00:00Z
p:P2888
wds:Q59217098-8B8D59F1-4797-4A34-9D28-044E2CA1D942
wdt:P2888
n6:1758-2652-11-s1-p24
p:P2093
wds:Q59217098-E097C4E2-D76D-4DF1-BAC3-88BCD62A84D5 wds:Q59217098-B280F894-1BF9-4C95-BC0C-560B1D201133 wds:Q59217098-10768B6F-F618-49D7-BE78-3521D9410FD2 wds:Q59217098-0B722874-EBDF-4275-A14A-1D07EBEF2A9F wds:Q59217098-7632AAD5-5CC2-492D-8DEF-BF57DD7B55B3 wds:Q59217098-51E0FB22-7C1B-440F-BB16-448815A0A648 wds:Q59217098-22BD8F84-4713-472F-B83A-339D7EAE0B2C
wdt:P2093
S Spinosa-Guzman JM Molina S De Meyer B Grinsztejn A Pozniak T Casteele K Arastéh
rdfs:label
POWER 3 analysis: 144-week efficacy and safety results for darunavir/ritonavir (DRV/r) 600/100 mg BID in treatment-experienced HIV patients POWER 3 analysis: 144-week efficacy and safety results for darunavir/ritonavir
skos:prefLabel
POWER 3 analysis: 144-week efficacy and safety results for darunavir/ritonavir (DRV/r) 600/100 mg BID in treatment-experienced HIV patients POWER 3 analysis: 144-week efficacy and safety results for darunavir/ritonavir
schema:name
POWER 3 analysis: 144-week efficacy and safety results for darunavir/ritonavir POWER 3 analysis: 144-week efficacy and safety results for darunavir/ritonavir (DRV/r) 600/100 mg BID in treatment-experienced HIV patients
p:P1476
wds:Q59217098-8F8746DB-F541-430A-A931-848C68EE713C
wdt:P1476
POWER 3 analysis: 144-week efficacy and safety results for darunavir/ritonavir (DRV/r) 600/100 mg BID in treatment-experienced HIV patients
p:P304
wds:Q59217098-7DCCC569-0C20-40C0-948F-499CDF64B5D4
wdt:P304
P24
p:P31
wds:Q59217098-CE9D1FAC-7DFB-47E1-A8D7-9A0BF73CC240
wdt:P31
wd:Q13442814
p:P921
wds:Q59217098-1F97BF54-CA15-48CA-B2AB-4A5F748EC28D wds:Q59217098-D5F52338-C57E-4E8B-979A-0F56D9B35C3A
wdt:P921
wd:Q18123741 wd:Q422618
p:P1433
wds:Q59217098-0F96334D-6A23-4F4E-B7F6-4E4A2125C385
wdt:P1433
wd:Q6296158
p:P433
wds:Q59217098-6B2E8EFA-1B69-46F4-ABA4-92931847087A
p:P478
wds:Q59217098-CB9501D6-09EB-43C9-BDA7-E7D227F63930
wdt:P433
Suppl 1
wdt:P478
11
p:P356
wds:Q59217098-48DCF89D-4C84-4D87-BEA1-404A4D20B591
wdtn:P356
n10:1758-2652-11-S1-P24
wdt:P356
10.1186/1758-2652-11-S1-P24
p:P6179
wds:Q59217098-036FC081-0860-4865-B57B-FB4717EE273A
wdt:P6179
1011015423